博雅生物：2025年上半年净利润2.25亿元，同比下降28.68%

Core Viewpoint - The company reported a revenue of 1.008 billion yuan for the first half of 2025, reflecting a year-on-year growth of 12.51%. However, the net profit decreased to 225 million yuan, a decline of 28.68% compared to the previous year [1] Financial Performance - Revenue for the first half of 2025 reached 1.008 billion yuan, marking a 12.51% increase year-on-year [1] - Net profit for the same period was 225 million yuan, which represents a 28.68% decrease year-on-year [1] Profit Distribution Plan - The board approved a profit distribution plan based on 504 million shares, proposing a cash dividend of 1.5 yuan per 10 shares (tax included) to all shareholders [1] - No bonus shares will be issued, and there will be no capital reserve conversion to additional shares [1]